University of Rochester
EMERGENCY INFORMATIONCALENDARDIRECTORYA TO Z INDEXCONTACTGIVINGTEXT ONLY
Currents--University of Rochester newspaper

Tech revenue rated in top ten

Companies around the world paid more than $26 million for commercial rights to University research during the 2003 fiscal year, according to the latest revenue report published by the Association for University Technology Managers (AUTM).

In addition, the report listed the University as having the fourth-highest licensing revenue for every dollar of research spending in the nation, behind only New York University, Wake Forest University, and Florida State University.

The 2003 revenues, which placed the University as the eighth highest revenue recipient in the nation, were surpassed in 2004 when the University brought in more than $33 million from licensing. The gains are indicative of an overall trend for the University, which has increased licensing revenue more than tenfold over the past five years, says Mark Coburn, director of the Office of Technology Transfer.

The most lucrative patents include the Hib vaccine, used to prevent meningitis in children, and Prevnar, which prevents several pneumococcal diseases in children. Other top licensed technology include "Blue Noise Mask," which improves the speed and appearance of digital images, and a technique for unprecedented accuracy in diagnosing aberrations in the eye.

"It is especially gratifying to be able to benchmark our licensing success and be ranked again among the top research universities in the nation. Once a university has achieved this level of revenue, companies and venture capitalists begin to recognize that the University is 'licensing- and start-up-company friendly,'" Coburn says.



Maintained by University Public Relations
Please send your comments and suggestions to:
Public Relations.